🚀 Pharmidex In Silico Drug Discovery – The Complete Pipeline! 🧬💻
February 28, 2025

At Pharmidex, we bring cutting-edge computational, structural, and molecular biology expertise to accelerate drug discovery and development. Whether you know your protein target and need to find a drug or have drug candidates and need to identify their target, our comprehensive in silico pipeline ensures success.

✨ Why Choose Pharmidex?
✅ Gold-standard software for precision modeling
✅ Hit and binding site identification for target validation
✅ Library mining, extraction, and de novo design
✅ 2D & 3D ligand-based modeling for enhanced screening
✅ Pathway exploration and molecular dynamics analysis
✅ X-ray crystallography & Cryo-EM structure refinement

From target determination to lead optimization, we streamline your drug discovery journey with advanced AI-driven solutions and deep scientific expertise.

📽️ Watch our latest video (5/5) showcasing how Pharmidex transforms drug discovery through computational innovation!

📩 Let’s collaborate and push the boundaries of pharmaceutical innovation together!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

December 16, 2025
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
More Posts